NDC 51672-1263-01 - Nystatin and Triamcinolone Acetonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1263
- Requested NDC
- 51672-1263-01
- Package NDCs from labels
- 51672-1263-1, 51672-1263-2, 51672-1263-3, 51672-1263-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-01-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nystatin and Triamcinolone Acetonide - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-01-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone Acetonide - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2025-08-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone Acetonide Cream, USP Nystatin and Triamcinolone Acetonide Ointment, USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Taro Pharmaceutical Industries Ltd. | 2025-07-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone Acetonide - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-06-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone Acetonide - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2023-09-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone Acetonide - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2023-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone Acetonide - Central Texas Community Health Centers | Central Texas Community Health Centers | 2016-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone Acetonide Cream, USP | H.J. Harkins Company, Inc. | Taro Pharmaceuticals Inc. | 2012-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone Acetonide - Physicians Total Care, Inc. | Physicians Total Care, Inc. | 2011-12-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Nystatin and Triamcinolone - Rebel Distributors Corp | Rebel Distributors Corp | 2010-10-22 | HUMAN PRESCRIPTION DRUG LABEL |
| NYSTATIN AND TRIAMCINOLONE - STAT RX LLC USA | STAT RX LLC USA | 2010-06-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1263-1 | Nystatin and Triamcinolone Acetonide | 15 g in 1 TUBE | CREAM | 15 | 6 | |
| 51672-1263-1 | Nystatin and Triamcinolone Acetonide | 1 in 1 CARTON | CREAM | 1 | 6 | |
| 51672-1263-2 | Nystatin and Triamcinolone Acetonide | 1 in 1 CARTON | CREAM | 1 | 6 | |
| 51672-1263-2 | Nystatin and Triamcinolone Acetonide | 30 g in 1 TUBE | CREAM | 30 | 6 | |
| 51672-1263-3 | Nystatin and Triamcinolone Acetonide | 60 g in 1 TUBE | CREAM | 60 | 6 | |
| 51672-1263-3 | Nystatin and Triamcinolone Acetonide | 1 in 1 CARTON | CREAM | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1263 | NYSTATIN AND TRIAMCINOLONE ACETONIDE OINTMENT NYSTATIN AND TRIAMCINOLONE ACETONIDE CREAM [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_2fd97fc5-cae5-43dd-a3c7-c9a03876153e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1263-1 | GM - Gram | 51672-1263 | d146d1bc-ab7d-4a38-b5bc-34a904668426 | 1 | 2012-07-24 |
| 51672-1263-2 | GM - Gram | 51672-1263 | 253f1035-667d-458c-b764-cdca0c2a2d1e | 1 | 2012-07-24 |
| 51672-1263-3 | GM - Gram | 51672-1263 | a32ae7e9-c681-4a95-a292-ec3c29623c27 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 3d5fafb9-62c9-ec69-e063-6394a90af8b9 | 2025-09-05 | Warnings | 4T6H12BN9U |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 3e0f655e-6100-f1dd-e063-6394a90af7b7 | 2025-09-05 | Warnings | 4T6H12BN9U |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 15FIX9V2JP |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30, 1 | ENSULIZOLE, HOMOSALATE, OCTINOXATE, TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 18130858-429c-4ed4-a75b-5bc014481250 | 2025-09-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 38C Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 0358a87d-8002-4f3e-851a-3a582d356edf | 2025-09-03 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 39N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 34dfc4c5-44f7-4531-97ba-8846ebe14724 | 2025-09-03 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 40C Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | cf4b6f45-d4ae-4665-87b4-c5af4910befa | 2025-09-03 | Warnings | 15FIX9V2JP |
| Pure6 ManiShield Hand Screen | ZINC OXIDE, TITANIUM DIOXIDE | GUANGZHOU SAWEILAN IMPORT & EXPORT TRADING CO., LTD | 3abcb6ba-1de8-55e7-e063-6294a90aecf1 | 2025-09-02 | Warnings | 15FIX9V2JP |
| toty Ilumina CC Creamy Compact 6N | TITANIUM DIOXIDE | Chipican LLC | 3da732e7-19b0-3195-e063-6394a90a9a0c | 2025-09-01 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 4 | ENSULIZOLE ,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3dba1360-f70f-e450-e063-6394a90a8c9f | 2025-09-01 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 33N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | e249507c-d536-4c1d-a99d-857ca1e833d8 | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 32W Medium Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | ba99edea-bf68-4118-8bb7-ea40322db46a | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 34W Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3a239897-9850-417f-8c00-e810a52540c1 | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 36N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | c495afc3-6486-4652-b743-958f28eccaca | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 35W Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 5440ed13-b07e-4c81-a407-d9ac68eaa483 | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 37W Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 9b2c4567-fde7-4b76-9988-b2cba2d3747e | 2025-08-29 | Warnings | 15FIX9V2JP |
| Nystatin and Triamcinolone Acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Encube Ethicals, Inc. | d33829fc-86df-4e28-82c3-9dbcd8a9e28d | 2025-08-29 | Adverse reactions | 1053697 BDF1O1C72E F446C597KA |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 2 | ENSULIZOLE,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3d55291c-9d4c-85c3-e063-6394a90af330 | 2025-08-27 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 3 | ENSULIZOLE ,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3d565612-ade5-bfb3-e063-6294a90a0c65 | 2025-08-27 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.